HEADER IMMUNE SYSTEM 05-JUN-15 5BVP TITLE THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A TITLE 2 HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA COMPND MOL_ID: 1; COMPND 2 MOLECULE: CANAKINUMAB FAB HEAVY-CHAIN; COMPND 3 CHAIN: H; COMPND 4 SYNONYM: ILARIS FAB; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INTERLEUKIN-1 BETA; COMPND 8 CHAIN: I; COMPND 9 FRAGMENT: FAB HEAVY-CHAIN, UNP RESIDUES 117-269; COMPND 10 SYNONYM: IL-1 BETA,CATABOLIN; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: CANAKINUMAB FAB LIGHT-CHAIN; COMPND 14 CHAIN: L; COMPND 15 SYNONYM: ILARIS FAB; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HOUSE MOUSE; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SP2/0; SOURCE 9 EXPRESSION_SYSTEM_CELL: MYELOMA; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: IL1B, IL1F2; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PET17; SOURCE 18 MOL_ID: 3; SOURCE 19 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 20 ORGANISM_COMMON: HUMAN; SOURCE 21 ORGANISM_TAXID: 9606; SOURCE 22 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 23 EXPRESSION_SYSTEM_COMMON: HOUSE MOUSE; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 25 EXPRESSION_SYSTEM_CELL_LINE: SP2/0; SOURCE 26 EXPRESSION_SYSTEM_CELL: MYELOMA KEYWDS IMMUNOGLOBULIN, FAB, CYTOKINE, BETA TREFOIL, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.M.RONDEAU REVDAT 5 10-JAN-24 5BVP 1 REMARK REVDAT 4 11-MAR-20 5BVP 1 REMARK SEQRES REVDAT 3 28-OCT-15 5BVP 1 JRNL REVDAT 2 30-SEP-15 5BVP 1 JRNL REVDAT 1 02-SEP-15 5BVP 0 JRNL AUTH J.M.RONDEAU,P.RAMAGE,M.ZURINI,H.GRAM JRNL TITL THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF JRNL TITL 2 CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1 JRNL TITL 3 BETA. JRNL REF MABS V. 7 1151 2015 JRNL REFN ESSN 1942-0870 JRNL PMID 26284424 JRNL DOI 10.1080/19420862.2015.1081323 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.22 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 28599 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1459 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.03 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2967 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2259 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2811 REMARK 3 BIN R VALUE (WORKING SET) : 0.2200 REMARK 3 BIN FREE R VALUE : 0.3362 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.26 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 156 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4489 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 254 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.39380 REMARK 3 B22 (A**2) : -4.55990 REMARK 3 B33 (A**2) : 4.95370 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.346 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.314 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.210 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.291 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.207 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4593 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6231 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1557 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 112 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 660 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4593 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 593 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5191 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.18 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.71 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.80 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { H|* } REMARK 3 ORIGIN FOR THE GROUP (A): 5.1865 -6.3075 -16.0422 REMARK 3 T TENSOR REMARK 3 T11: 0.0130 T22: -0.0777 REMARK 3 T33: -0.1106 T12: -0.1847 REMARK 3 T13: -0.0113 T23: -0.0983 REMARK 3 L TENSOR REMARK 3 L11: 1.4614 L22: 0.1168 REMARK 3 L33: 4.3033 L12: -0.2083 REMARK 3 L13: -2.0677 L23: -0.4293 REMARK 3 S TENSOR REMARK 3 S11: 0.3012 S12: -0.3974 S13: 0.1934 REMARK 3 S21: 0.2239 S22: -0.1763 S23: -0.0823 REMARK 3 S31: -0.9076 S32: 0.6054 S33: -0.1249 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { I|* } REMARK 3 ORIGIN FOR THE GROUP (A): 16.3024 -17.6275 -59.3426 REMARK 3 T TENSOR REMARK 3 T11: -0.0450 T22: -0.1024 REMARK 3 T33: -0.0993 T12: 0.1237 REMARK 3 T13: 0.0764 T23: 0.0356 REMARK 3 L TENSOR REMARK 3 L11: 2.8102 L22: 2.2102 REMARK 3 L33: 3.5119 L12: 0.1746 REMARK 3 L13: -0.8190 L23: -1.2722 REMARK 3 S TENSOR REMARK 3 S11: -0.0294 S12: 0.2631 S13: -0.2526 REMARK 3 S21: -0.5620 S22: -0.2505 S23: -0.1769 REMARK 3 S31: 0.5201 S32: 0.2053 S33: 0.2799 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { L|* } REMARK 3 ORIGIN FOR THE GROUP (A): -11.4990 -8.9867 -21.0785 REMARK 3 T TENSOR REMARK 3 T11: -0.0836 T22: -0.0600 REMARK 3 T33: -0.1232 T12: 0.0968 REMARK 3 T13: 0.0127 T23: -0.0667 REMARK 3 L TENSOR REMARK 3 L11: 0.7601 L22: 0.0000 REMARK 3 L33: 3.8226 L12: -0.2245 REMARK 3 L13: -0.5866 L23: -0.3082 REMARK 3 S TENSOR REMARK 3 S11: 0.0815 S12: 0.0350 S13: 0.1530 REMARK 3 S21: 0.1441 S22: -0.0171 S23: -0.0297 REMARK 3 S31: -0.7201 S32: -0.7081 S33: -0.0644 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5BVP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-JUN-15. REMARK 100 THE DEPOSITION ID IS D_1000210612. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 1.98.5 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK 1.98.5 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28731 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.03800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : 0.17900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2I1B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.09M MIB BUFFER PH 5.0, 22.5% PEG REMARK 280 1,500, 0.01M TRIS-HCL PH 8.5, 0.4M LICL, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.46400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 95.85200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.14250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 95.85200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.46400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.14250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, I, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS H 221 REMARK 465 ASP H 222 REMARK 465 LYS H 223 REMARK 465 THR H 224 REMARK 465 HIS H 225 REMARK 465 ALA I 1 REMARK 465 PRO I 2 REMARK 465 THR I 137 REMARK 465 LYS I 138 REMARK 465 CYS L 214 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP H 149 68.78 62.18 REMARK 500 GLU I 50 95.15 -53.25 REMARK 500 ASP I 54 3.40 80.83 REMARK 500 LYS L 16 -5.90 88.26 REMARK 500 ALA L 51 -47.19 69.91 REMARK 500 SER L 77 86.83 81.05 REMARK 500 LYS L 169 -72.57 -97.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL I 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL L 301 DBREF 5BVP H 1 225 PDB 5BVP 5BVP 1 225 DBREF 5BVP I 1 153 UNP P01584 IL1B_HUMAN 117 269 DBREF 5BVP L 1 214 PDB 5BVP 5BVP 1 214 SEQRES 1 H 225 PCA VAL GLN LEU VAL GLU SER GLY GLY GLY VAL VAL GLN SEQRES 2 H 225 PRO GLY ARG SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 H 225 PHE THR PHE SER VAL TYR GLY MET ASN TRP VAL ARG GLN SEQRES 4 H 225 ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA ILE ILE TRP SEQRES 5 H 225 TYR ASP GLY ASP ASN GLN TYR TYR ALA ASP SER VAL LYS SEQRES 6 H 225 GLY ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR SEQRES 7 H 225 LEU TYR LEU GLN MET ASN GLY LEU ARG ALA GLU ASP THR SEQRES 8 H 225 ALA VAL TYR TYR CYS ALA ARG ASP LEU ARG THR GLY PRO SEQRES 9 H 225 PHE ASP TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 10 H 225 SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 11 H 225 PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU SEQRES 12 H 225 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR SEQRES 13 H 225 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 14 H 225 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 15 H 225 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 16 H 225 THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER SEQRES 17 H 225 ASN THR LYS VAL ASP LYS ARG VAL GLU PRO LYS SER CYS SEQRES 18 H 225 ASP LYS THR HIS SEQRES 1 I 153 ALA PRO VAL ARG SER LEU ASN CYS THR LEU ARG ASP SER SEQRES 2 I 153 GLN GLN LYS SER LEU VAL MET SER GLY PRO TYR GLU LEU SEQRES 3 I 153 LYS ALA LEU HIS LEU GLN GLY GLN ASP MET GLU GLN GLN SEQRES 4 I 153 VAL VAL PHE SER MET SER PHE VAL GLN GLY GLU GLU SER SEQRES 5 I 153 ASN ASP LYS ILE PRO VAL ALA LEU GLY LEU LYS GLU LYS SEQRES 6 I 153 ASN LEU TYR LEU SER CYS VAL LEU LYS ASP ASP LYS PRO SEQRES 7 I 153 THR LEU GLN LEU GLU SER VAL ASP PRO LYS ASN TYR PRO SEQRES 8 I 153 LYS LYS LYS MET GLU LYS ARG PHE VAL PHE ASN LYS ILE SEQRES 9 I 153 GLU ILE ASN ASN LYS LEU GLU PHE GLU SER ALA GLN PHE SEQRES 10 I 153 PRO ASN TRP TYR ILE SER THR SER GLN ALA GLU ASN MET SEQRES 11 I 153 PRO VAL PHE LEU GLY GLY THR LYS GLY GLY GLN ASP ILE SEQRES 12 I 153 THR ASP PHE THR MET GLN PHE VAL SER SER SEQRES 1 L 214 GLU ILE VAL LEU THR GLN SER PRO ASP PHE GLN SER VAL SEQRES 2 L 214 THR PRO LYS GLU LYS VAL THR ILE THR CYS ARG ALA SER SEQRES 3 L 214 GLN SER ILE GLY SER SER LEU HIS TRP TYR GLN GLN LYS SEQRES 4 L 214 PRO ASP GLN SER PRO LYS LEU LEU ILE LYS TYR ALA SER SEQRES 5 L 214 GLN SER PHE SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 L 214 GLY SER GLY THR ASP PHE THR LEU THR ILE ASN SER LEU SEQRES 7 L 214 GLU ALA GLU ASP ALA ALA ALA TYR TYR CYS HIS GLN SER SEQRES 8 L 214 SER SER LEU PRO PHE THR PHE GLY PRO GLY THR LYS VAL SEQRES 9 L 214 ASP ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 L 214 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 L 214 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 L 214 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 L 214 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 L 214 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 L 214 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 L 214 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 L 214 PHE ASN ARG GLY GLU CYS HET PCA H 1 8 HET CL I 201 1 HET CL L 301 1 HETNAM PCA PYROGLUTAMIC ACID HETNAM CL CHLORIDE ION FORMUL 1 PCA C5 H7 N O3 FORMUL 4 CL 2(CL 1-) FORMUL 6 HOH *254(H2 O) HELIX 1 AA1 THR H 28 TYR H 32 5 5 HELIX 2 AA2 ARG H 87 THR H 91 5 5 HELIX 3 AA3 SER H 161 ALA H 163 5 3 HELIX 4 AA4 SER H 192 LEU H 194 5 3 HELIX 5 AA5 LYS H 206 ASN H 209 5 4 HELIX 6 AA6 GLN I 32 GLN I 39 5 8 HELIX 7 AA7 ASP I 86 TYR I 90 5 5 HELIX 8 AA8 GLU I 96 ARG I 98 5 3 HELIX 9 AA9 GLU L 79 ALA L 83 5 5 HELIX 10 AB1 SER L 121 SER L 127 1 7 HELIX 11 AB2 LYS L 183 HIS L 189 1 7 SHEET 1 AA1 4 GLN H 3 SER H 7 0 SHEET 2 AA1 4 LEU H 18 SER H 25 -1 O SER H 21 N SER H 7 SHEET 3 AA1 4 THR H 78 MET H 83 -1 O LEU H 81 N LEU H 20 SHEET 4 AA1 4 PHE H 68 ASP H 73 -1 N SER H 71 O TYR H 80 SHEET 1 AA2 6 VAL H 11 VAL H 12 0 SHEET 2 AA2 6 THR H 112 VAL H 116 1 O THR H 115 N VAL H 12 SHEET 3 AA2 6 ALA H 92 ASP H 99 -1 N TYR H 94 O THR H 112 SHEET 4 AA2 6 MET H 34 GLN H 39 -1 N VAL H 37 O TYR H 95 SHEET 5 AA2 6 LEU H 45 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 AA2 6 GLN H 58 TYR H 60 -1 O TYR H 59 N ILE H 50 SHEET 1 AA3 4 VAL H 11 VAL H 12 0 SHEET 2 AA3 4 THR H 112 VAL H 116 1 O THR H 115 N VAL H 12 SHEET 3 AA3 4 ALA H 92 ASP H 99 -1 N TYR H 94 O THR H 112 SHEET 4 AA3 4 PHE H 105 TRP H 108 -1 O TYR H 107 N ARG H 98 SHEET 1 AA4 4 SER H 125 LEU H 129 0 SHEET 2 AA4 4 THR H 140 TYR H 150 -1 O LYS H 148 N SER H 125 SHEET 3 AA4 4 TYR H 181 PRO H 190 -1 O VAL H 189 N ALA H 141 SHEET 4 AA4 4 VAL H 168 THR H 170 -1 N HIS H 169 O VAL H 186 SHEET 1 AA5 4 SER H 125 LEU H 129 0 SHEET 2 AA5 4 THR H 140 TYR H 150 -1 O LYS H 148 N SER H 125 SHEET 3 AA5 4 TYR H 181 PRO H 190 -1 O VAL H 189 N ALA H 141 SHEET 4 AA5 4 VAL H 174 LEU H 175 -1 N VAL H 174 O SER H 182 SHEET 1 AA6 3 THR H 156 TRP H 159 0 SHEET 2 AA6 3 ILE H 200 HIS H 205 -1 O ASN H 202 N SER H 158 SHEET 3 AA6 3 THR H 210 ARG H 215 -1 O VAL H 212 N VAL H 203 SHEET 1 AA7 9 LYS I 77 SER I 84 0 SHEET 2 AA7 9 LEU I 67 LYS I 74 -1 N TYR I 68 O GLU I 83 SHEET 3 AA7 9 LYS I 55 LEU I 62 -1 N LEU I 62 O LEU I 67 SHEET 4 AA7 9 VAL I 100 ILE I 106 -1 O PHE I 101 N VAL I 58 SHEET 5 AA7 9 LYS I 109 SER I 114 -1 O GLU I 113 N ASN I 102 SHEET 6 AA7 9 PHE I 146 PHE I 150 -1 O PHE I 146 N LEU I 110 SHEET 7 AA7 9 SER I 5 ASP I 12 -1 N ARG I 11 O THR I 147 SHEET 8 AA7 9 PHE I 42 PHE I 46 -1 O PHE I 42 N CYS I 8 SHEET 9 AA7 9 LYS I 55 LEU I 62 -1 O GLY I 61 N SER I 43 SHEET 1 AA8 3 SER I 17 GLY I 22 0 SHEET 2 AA8 3 GLU I 25 LEU I 29 -1 O LEU I 29 N SER I 17 SHEET 3 AA8 3 MET I 130 PRO I 131 -1 O MET I 130 N ALA I 28 SHEET 1 AA9 2 TYR I 121 SER I 123 0 SHEET 2 AA9 2 PHE I 133 GLY I 135 -1 O PHE I 133 N SER I 123 SHEET 1 AB1 4 LEU L 4 SER L 7 0 SHEET 2 AB1 4 LYS L 18 ALA L 25 -1 O ARG L 24 N THR L 5 SHEET 3 AB1 4 ASP L 70 ASN L 76 -1 O ILE L 75 N VAL L 19 SHEET 4 AB1 4 PHE L 62 SER L 67 -1 N SER L 63 O THR L 74 SHEET 1 AB2 6 PHE L 10 VAL L 13 0 SHEET 2 AB2 6 THR L 102 ILE L 106 1 O ASP L 105 N GLN L 11 SHEET 3 AB2 6 ALA L 84 GLN L 90 -1 N ALA L 84 O VAL L 104 SHEET 4 AB2 6 LEU L 33 GLN L 38 -1 N HIS L 34 O HIS L 89 SHEET 5 AB2 6 LYS L 45 LYS L 49 -1 O LEU L 47 N TRP L 35 SHEET 6 AB2 6 GLN L 53 SER L 54 -1 O GLN L 53 N LYS L 49 SHEET 1 AB3 4 PHE L 10 VAL L 13 0 SHEET 2 AB3 4 THR L 102 ILE L 106 1 O ASP L 105 N GLN L 11 SHEET 3 AB3 4 ALA L 84 GLN L 90 -1 N ALA L 84 O VAL L 104 SHEET 4 AB3 4 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SHEET 1 AB4 4 SER L 114 PHE L 118 0 SHEET 2 AB4 4 THR L 129 PHE L 139 -1 O LEU L 135 N PHE L 116 SHEET 3 AB4 4 TYR L 173 SER L 182 -1 O LEU L 179 N VAL L 132 SHEET 4 AB4 4 SER L 159 VAL L 163 -1 N SER L 162 O SER L 176 SHEET 1 AB5 3 LYS L 145 VAL L 150 0 SHEET 2 AB5 3 VAL L 191 THR L 197 -1 O ALA L 193 N LYS L 149 SHEET 3 AB5 3 VAL L 205 ASN L 210 -1 O VAL L 205 N VAL L 196 SSBOND 1 CYS H 22 CYS H 96 1555 1555 2.04 SSBOND 2 CYS H 145 CYS H 201 1555 1555 2.03 SSBOND 3 CYS L 23 CYS L 88 1555 1555 2.04 SSBOND 4 CYS L 134 CYS L 194 1555 1555 2.04 LINK C PCA H 1 N VAL H 2 1555 1555 1.35 CISPEP 1 PHE H 151 PRO H 152 0 -8.26 CISPEP 2 GLU H 153 PRO H 154 0 -2.84 CISPEP 3 TYR I 90 PRO I 91 0 -3.96 CISPEP 4 SER L 7 PRO L 8 0 -0.57 CISPEP 5 LEU L 94 PRO L 95 0 -3.15 CISPEP 6 TYR L 140 PRO L 141 0 1.53 SITE 1 AC1 2 ARG I 11 MET I 36 SITE 1 AC2 3 ARG I 98 PRO L 59 ARG L 61 CRYST1 50.928 56.285 191.704 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019636 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017767 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005216 0.00000 HETATM 1 N PCA H 1 18.385 -27.749 -26.207 1.00 62.04 N ANISOU 1 N PCA H 1 6898 9377 7299 1751 1096 2089 N HETATM 2 CA PCA H 1 17.157 -27.180 -26.768 1.00 58.44 C ANISOU 2 CA PCA H 1 6565 8586 7052 1461 994 1779 C HETATM 3 CB PCA H 1 16.071 -27.374 -25.663 1.00 59.36 C ANISOU 3 CB PCA H 1 6791 8543 7220 1379 1035 1662 C HETATM 4 CG PCA H 1 16.952 -27.433 -24.370 1.00 61.94 C ANISOU 4 CG PCA H 1 6936 9256 7342 1538 1035 1894 C HETATM 5 CD PCA H 1 18.366 -27.774 -24.835 1.00 64.93 C ANISOU 5 CD PCA H 1 7186 9924 7559 1789 1098 2163 C HETATM 6 OE PCA H 1 19.348 -28.041 -24.078 1.00 69.00 O ANISOU 6 OE PCA H 1 7539 10816 7863 2006 1147 2419 O HETATM 7 C PCA H 1 17.302 -25.678 -27.002 1.00 56.41 C ANISOU 7 C PCA H 1 6111 8505 6818 1182 713 1647 C HETATM 8 O PCA H 1 18.156 -25.040 -26.379 1.00 56.39 O ANISOU 8 O PCA H 1 5884 8872 6669 1146 587 1753 O